Immunocore Holdings plc (FRA:6YG)
Germany flag Germany · Delayed Price · Currency is EUR
31.40
0.00 (0.00%)
At close: Aug 26, 2026

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $314.85M USD in the twelve months ending June 30, 2026, down -11.60% year-over-year. In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth.

Revenue (ttm)
$314.85M
Revenue Growth
-11.60%
P/S Ratio
4.35
Revenue / Employee
$600.85K
Employees
524
Market Cap
1.64B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M215.75M640.71%
Dec 31, 202233.67M-2.81M-7.70%
Dec 31, 202136.48M-4.69M-11.39%
Dec 31, 202041.17M7.13M20.95%
Dec 31, 201934.04M3.91M12.98%
Dec 31, 201830.13M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Biotest GmbH & Co. KGaA648.90M
Novogenia AG54.30M
Paion AG14.81M
MagForce AG1.08M
Biomark Diagnostics37.15K
co.don AG22.00K
bioXXmed AG16.73K
2invest AG-1.64M
Revenue Rankings